|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Meza R, Meernik C, Jeon J and Cote ML:
Lung cancer incidence trends by gender, race and histology in the
United States, 1973–2010. PLoS One. 10:e01213232015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Forde PM and Ettinger DS: Targeted therapy
for non-small-cell lung cancer: Past, present and future. Expert
Rev Anticancer Ther. 13:745–758. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pei K, Zhu JJ, Wang CE, Xie QL and Guo JY:
MicroRNA-185-5p modulates chemosensitivity of human non-small cell
lung cancer to cisplatin via targeting ABCC1. Eur Rev Med Pharmacol
Sci. 20:4697–4704. 2016.PubMed/NCBI
|
|
5
|
Johnson KN, Gooden G, Gonzalez P,
Sepulveda M, Gorgol L, Petricoin EF, Pierobon M, Byron S, Glen J,
Ahluwalia M, et al: BM-15 targeting MEK is a novel and effective
treatment strategy of lung CNS metastasis. Neuro Oncol. 16 (Suppl
5):v352014. View Article : Google Scholar
|
|
6
|
Gholipour Baradari A, Firouzian A, Zamani
Kiasari A, Aarabi M, Emadi SA, Davanlou A, Motamed N and Yousefi
Abdolmaleki E: Effect of etomidate versus combination of
propofol-ketamine and thiopental-ketamine on hemodynamic response
to laryngoscopy and intubation: A randomized double blind clinical
trial. Anesth Pain Med. 6:e300712016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang X, Teng Y, Yang H and Ma J: Propofol
inhibits invasion and growth of ovarian cancer cells via regulating
miR-9/NF-kB signal. Braz J Med Biol Res. 49:e57172016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ecimovic P, Murray D, Doran P and Buggy
DJ: Propofol and bupivacaine in breast cancer cell function in
vitro-role of the NET1 gene. Anticancer Res. 34:1321–1331.
2014.PubMed/NCBI
|
|
9
|
Xu YJ, Li SY, Cheng Q, Chen WK, Wang SL,
Ren Y and Miao CH: Effects of anaesthesia on proliferation,
invasion and apoptosis of LoVo colon cancer cells in vitro.
Anaesthesia. 71:147–154. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang J, Zhang D, Wu GQ, Feng ZY and Zhu
SM: Propofol inhibits the adhesion of hepatocellular carcinoma
cells by upregulating microRNA-199a and downregulating MMP-9
expression. Hepatobiliary Pancreat Dis Int. 12:305–309. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun H and Gao D: Propofol suppresses
growth, migration and invasion of A549 cells by down-regulation of
miR-372. BMC Cancer. 18:12522018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu WZ and Liu N: Propofol inhibits lung
cancer A549 cells growth and epithelial-mesenchymal transition
process by upregulation of microRNA-1284. Oncol Res. 27:1–8. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang N, Liang Y, Yang P, Yang T and Jiang
L: Propofol inhibits lung cancer cell viability and induces cell
apoptosis by upregulating microRNA-486 expression. Braz J Med Biol
Res. 50:e57942017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cserni G, Chmielik E, Cserni B and Tot T:
The new TNM-based staging of breast cancer. Virchows Arch.
472:697–703. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cancer Genome Atlas Research Network, .
Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA,
Ellrott K, Shmulevich I, Sander C and Stuart JM: The cancer genome
atlas pan-cancer analysis project. Nat Genet. 45:1113–1120. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang DD, Kuan CY, Whitmarsh AJ, Rincón M,
Zheng TS, Davis RJ, Rakic P and Flavell RA: Absence of
excitotoxicity-induced apoptosis in the hippocampus of mice lacking
the Jnk3 gene. Nature. 389:865–870. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ying J, Li H, Cui Y, Wong AH, Langford C
and Tao Q: Epigenetic disruption of two proapoptotic genes
MAPK10/JNK3 and PTPN13/FAP-1 in multiple lymphomas and carcinomas
through hypermethylation of a common bidirectional promoter.
Leukemia. 20:1173–1175. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li L and Luo Z: Dysregulated miR-27a-3p
promotes nasopharyngeal carcinoma cell proliferation and migration
by targeting Mapk10. Oncol Rep. 37:2679–2687. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ulivi P, Petracci E, Marisi G, Baglivo S,
Chiari R, Billi M, Canale M, Pasini L, Racanicchi S, Vagheggini A,
et al: Prognostic role of circulating miRNAs in early-stage
non-small cell lung cancer. J Clin Med. 8:E1312019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xie Y, Liu Y, Fan X, Zhang L, Li Q, Li S,
Wang H and Xiao Y: MicroRNA-21 promotes progression of breast
cancer via inhibition of mitogen-activated protein kinase10
(MAPK10). Biosci Rep. Aug 2–2019.(Epub ahead of print).
|
|
25
|
Vasileiou I, Xanthos T, Koudouna E, Perrea
D, Klonaris C, Katsargyris A and Papadimitriou L: Propofol: A
review of its non-anaesthetic effects. Eur J Pharmacol. 605:1–8.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun H, Zhang G, Ai B, Zhang H, Kong X, Lee
WT, Zheng H, Yan T and Sun L: A systematic review: Comparative
analysis of the effects of propofol and sevoflurane on
postoperative cognitive function in elderly patients with lung
cancer. BMC Cancer. 19:12482019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gheorghita E, Pruna VM, Neagoe L, Bucur C,
Cristescu C and Gorgan MR: Perioperative management of patients
with lung carcinoma and cerebral metastases. Maedica (Buchar).
5:28–33. 2010.PubMed/NCBI
|
|
28
|
Yap A, Lopez-Olivo MA, Dubowitz J, Hiller
J and Riedel B; Global Onco-Anesthesia Research Collaboration
Group, : Anesthetic technique and cancer outcomes: A meta-analysis
of total intravenous versus volatile anesthesia. Can J Anaesth.
66:546–561. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lv X, Zhou X, Yan J, Jiang J and Jiang H:
Propofol inhibits LPS-induced apoptosis in lung epithelial cell
line, BEAS-2B. Biomed Pharmacother. 87:180–187. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang N, Liang Y, Yang P and Ji F: Propofol
suppresses LPS-induced nuclear accumulation of HIF-1α and tumor
aggressiveness in non-small cell lung cancer. Oncol Rep.
37:2611–2619. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xing SG, Zhang KJ, Qu JH, Ren YD and Luan
Q: Propofol induces apoptosis of non-small cell lung cancer cells
via ERK1/2-dependent upregulation of PUMA. Eur Rev Med Pharmacol
Sci. 22:4341–4349. 2018.PubMed/NCBI
|
|
32
|
Wang G, Liu J, Gao J and Zheng X:
Comparison of the effects of sevoflurane and propofol anesthesia on
pulmonary function, MMP-9 and postoperative cognition in patients
receiving lung cancer resection. Oncol Lett. 17:3399–3405.
2019.PubMed/NCBI
|
|
33
|
Wojczakowski W, Kobylarek D, Lindner J,
Limphaibool N and Kaczmarek M: MicroRNAs-novel biomarkers for
malignant pleural effusions. Contemp Oncol (Pozn). 23:133–140.
2019.PubMed/NCBI
|
|
34
|
Li G, Fang J, Wang Y, Wang H and Sun CC:
MiRNA-based therapeutic strategy in lung cancer. Curr Pharm Des.
23:6011–6018. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Du Z, Wu J, Wang J, Liang Y, Zhang S,
Shang Z and Zuo W: MicroRNA-1298 is downregulated in non-small cell
lung cancer and suppresses tumor progression in tumor cells. Diagn
Pathol. 14:1322019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang L, Ge W and Geng J: MiR-425
regulates cell proliferation, migration and apoptosis by targeting
AMPH-1 in non-small-cell lung cancer. Pathol Res Pract.
215:1527052019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Duan FG, Wang MF, Cao YB, Dan Li, Li RZ,
Fan XX, Khan I, Lai HL, Zhang YZ, Hsiao WW, et al: MicroRNA-421
confers paclitaxel resistance by binding to the KEAP1 3′UTR and
predicts poor survival in non-small cell lung cancer. Cell Death
Dis. 10:8212019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang M, Shen H, Qiu C, Ni Y, Wang L, Dong
W, Liao Y and Du J: High expression of miR-21 and miR-155 predicts
recurrence and unfavourable survival in non-small cell lung cancer.
Eur J Cancer. 49:604–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Abdollahi A, Rahmati S, Ghaderi B, Sigari
N, Nikkhoo B, Sharifi K and Abdi M: A combined panel of circulating
microRNA as a diagnostic tool for detection of the non-small cell
lung cancer. QJM. 112:779–785. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Song F, Xuan Z, Yang X, Ye X, Pan Z and
Fang Q: Identification of key microRNAs and hub genes in
non-small-cell lung cancer using integrative bioinformatics and
functional analyses. J Cell Biochem. 121:2690–2703. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Du Q, Zhang X, Zhang X, Wei M, Xu H and
Wang S: Propofol inhibits proliferation and epithelial-mesenchymal
transition of MCF-7 cells by suppressing miR-21 expression. Artif
Cells Nanomed Biotechnol. 47:1265–1271. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu Z, Zhang J, Hong G, Quan J, Zhang L
and Yu M: Propofol inhibits growth and invasion of pancreatic
cancer cells through regulation of the miR-21/slug signaling
pathway. Am J Transl Res. 8:4120–4133. 2016.PubMed/NCBI
|
|
43
|
Twaroski DM, Yan Y, Olson JM, Bosnjak ZJ
and Bai X: Down-regulation of microRNA-21 is involved in the
propofol-induced neurotoxicity observed in human stem cell-derived
neurons. Anesthesiology. 121:786–800. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yoo KH, Park YK, Kim HS, Jung WW and Chang
SG: Identification of MAPK10 as a novel epigenetic marker for
chromophobe kidney cancer. Pathol Int. 61:52–54. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Dai F, Zhang Y and Chen Y: Involvement of
miR-29b signaling in the sensitivity to chemotherapy in patients
with ovarian carcinoma. Hum Pathol. 45:1285–1293. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu G, Pei F, Yang F, Li L, Amin AD, Liu
S, Buchan JR and Cho WC: Role of autophagy and apoptosis in
non-small-cell lung cancer. Int J Mol Sci. 18:E3672017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lv M, Shao S, Zhang Q, Zhuang X and Qiao
T: Acetyl-11-Keto- β-Boswellic acid exerts the anti-cancer effects
via cell cycle arrest, apoptosis induction and autophagy
suppression in non-small cell lung cancer cells. Onco Targets Ther.
13:733–744. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lee JH, Lee HH, Ryu KD, Kim M, Ko D, Chung
KS, Hassan AHE, Lee SH, Lee JY and Lee KT: KCP10043F represses the
proliferation of human non-small cell lung cancer cells by
caspase-mediated apoptosis via STAT3 inactivation. J Clin Med.
9:E7042020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tan LJ, Liu JT, Yang M, Ju T and Zhang YS:
LncRNA ASB16-AS1 promotes proliferation and inhibits apoptosis of
non-small cell lung cancer cells by activating the Wnt/β catenin
signaling pathway. Eur Rev Med Pharmacol Sci. 24:1870–1876.
2020.PubMed/NCBI
|
